Globe News Wire

Category

Orion Group Interim Report 1-9/2020

ORION CORPORATION            INTERIM REPORT 1-9/2020    21 OCTOBER 2020 at 12:00 noon EEST Orion Group Interim Report 1-9/2020 This is a summary of Orion’s Interim Report 1-9/2020. The complete...

Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-1777, an Investigational Topical “Soft” JAK 1/3 Inhibitor, for the Treatment of Moderate to Severe Atopic Dermatitis

WAYNE, Pa., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that the first patient has been dosed in...

Baudax Bio Provides Commercial and Corporate Update

ANJESO® Launch Underway; Over 50 Institutions have Added ANJESO to Their FormulariesANJESO Users Giving Highly Positive Feedback; Average Order Size Has Increased 75% Since Launch, Despite Ongoing COVID-related Impact to Access Company Executes Strategic Transaction...